Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Ila M. Saunders"'
Autor:
Tigran Makunts, Ila M. Saunders, Isaac V. Cohen, Mengxing Li, Talar Moumedjian, Masara A. Issa, Keith Burkhart, Peter Lee, Sandip Pravin Patel, Ruben Abagyan
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Abstract Antibodies targeting the PD-1, PD-L1, and CTLA-4 immune checkpoint axis have been used in a variety of tumor types. They achieve anti-tumor activity through activating the patient’s own immune system to target immune response evading cance
Externí odkaz:
https://doaj.org/article/f9e5c40ece6d4172afc9cd95cfa7fd22
Publikováno v:
Exploratory Research in Clinical and Social Pharmacy, Vol 6, Iss , Pp 100136- (2022)
Background: In the US, medical costs for cancer patients have grown from $27 billion in 1990 to $174 billion in 2020. The increased financial strain that cancer patients and survivors endure is referred to as financial toxicity. Objective: To quantif
Externí odkaz:
https://doaj.org/article/67b852744fe24bcf9f661f46de814325
Autor:
Aryana Sepassi, Ila M. Saunders, Mark Bounthavong, Randy A. Taplitz, Cathy Logan, Jonathan H. Watanabe
Publikováno v:
PharmacoEconomics-open, vol 7, iss 3
PurposeThe aim of this study was to assess the cost effectiveness of letermovir prophylaxis with the option for subsequent pre-emptive therapy (PET) for the prevention of cytomegalovirus (CMV) infection compared with a PET-only scenario in adult allo
Autor:
Jacinda C. Abdul-Mutakabbir, Frank Tillman, Jasmine R. Marcelin, Ila M. Saunders, Vibhuti Arya
Publikováno v:
Journal of the American Pharmacists Association. 63:424-429
In the United States, coronavirus disease 2019 (COVID-19) has resulted in more than 95 million infections and 1 million deaths (as of September 2022), with individuals of racially/ethnically minoritized groups being disproportionately represented amo
Autor:
Aryana Sepassi, Ila M. Saunders, Mark Bounthavong, Randy A. Taplitz, Cathy Logan, Jonathan H. Watanabe
Publikováno v:
Journal of the American Pharmacists Association.
Autor:
Engie Salama, Stepfanie Lam, Wilson I. Gonsalves, Dimitrios Tzachanis, Jeremiah D. Momper, Ila M. Saunders
Publikováno v:
The Annals of pharmacotherapy, vol 57, iss 1
Background Lenalidomide is an immunomodulatory drug used to treat multiple myeloma that requires renal dosing adjustment based on Cockcroft-Gault (CG). Various equations to estimate kidney function exist and pose a potential issue with lenalidomide d
Autor:
Caroline L. Ko, Jacinda C. Abdul-Mutakabbir, Kevin N. Astle, Aiman Bandali, Judah E. Brown, Lindsey M. Childs-Kean, Elizabeth B. Hirsch, Jason Mordino, Ila M. Saunders, Britny R. Brown
Publikováno v:
Journal of the American Pharmacists Association. 62:701-705
Due to the effects of structural racism, disproportionately lower numbers of Black, Hispanic or LatinX, American Indian, and Alaska Native students pursue a career in pharmacy and successfully matriculate into the profession. Despite these disparitie
Data from Phenotypic and Genomic Determinants of Immunotherapy Response Associated with Squamousness
Autor:
Razelle Kurzrock, Gregory A. Daniels, Vincent A. Miller, Garrett M. Frampton, Meagan Montesion, Ila M. Saunders, Ryosuke Okamura, Ranajoy Chattopadhyay, Shumei Kato, Aaron M. Goodman
Advanced and metastatic squamous cell carcinomas (SCC) are common and difficult-to-treat malignancies. We assessed 75 immunotherapy-treated patients with SCC from a clinically annotated database of 2,651 patients, as well as 9,407 patients from a dei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3ac58723fa9d594eb1009b4d8e1bb6d
https://doi.org/10.1158/2326-6066.c.6549955
https://doi.org/10.1158/2326-6066.c.6549955
Autor:
Razelle Kurzrock, Gregory A. Daniels, Vincent A. Miller, Garrett M. Frampton, Meagan Montesion, Ila M. Saunders, Ryosuke Okamura, Ranajoy Chattopadhyay, Shumei Kato, Aaron M. Goodman
Supplemental Tables 1-3 and Supplemental Figures 1-5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5da66bb4a8978f328c7f0826ad1e19f1
https://doi.org/10.1158/2326-6066.22542505.v1
https://doi.org/10.1158/2326-6066.22542505.v1
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:e161-e184
Acute myeloid leukemia (AML) is the most common acute leukemia of adults, with a five-year survival that remains poor (approximately 25%). Knowledge and understanding of AML genomics have expanded tremendously over the past decade and are now include